Welcome! We regret to inform you that the Injury Board National News Desk has been discontinued. Feel free to browse around and enjoy our previously published articles, or visit The Injury Blog Network for the latest in personal injury news.

CTC Chip Finds One Cancer Cell Among One Billion

Posted by Jane Akre
Thursday, July 03, 2008 11:11 AM EST
Category: Major Medical, Protecting Your Family
Tags: FDA and Prescription Drugs, Nanotechnology, Toxic Substances, Lung Cancer

Nanotechnology used at Mass General Hospital to pinpoint a single cancer cell for treatment

LEARN MORE

 

IMAGE SOURCE:  Wikimedia Commons/ Optical Microscope from: Open Source Handbook of Nanoscience,/  author: Kristian Molhave

 

Talk about finding a needle in a haystack – how about finding one cancer cell circulating among one billion healthy ones?

That the promise of a new technology, a microchip scanner, no bigger than a business card, that searches a patient’s blood looking for a stray tumor cell. 

Using the latest in nanotechnology, a CTC-chip, or circulating tumor cells, has been invented by Massachusetts General Hospital and is being heralded as a huge improvement over standard biopsies and CAT scans to track the progress of a cancer.

The device has 78,000 posts inside to trap the cancer cells with a glue-like substance.  In the study, researchers identified a non-small-cell lung cancer, which is the deadliest form of the disease, after taking blood from 27 lung cancer patients.

Once a cancer cell is captured, its genetic fingerprint is taken. Then the most effective drug for that particular type of cancer can be custom-fitted for treatment before the cancer spreads.

The researchers from Massachusetts General and Harvard found among the 27 patients, 23 that had the EGFR gene mutation. The CTC chip found 99 percent of circulating cancer cells and 92 percent of EGFR gene mutations.

“Someday, we might pick our cancer drugs like we pick our antibiotics,” Dr. Roy Herbst, a lung cancer specialist at M.D. Anderson Cancer Center in Houston tells the Boston Globe.

Repeated scans can show whether a drug is working.  The CTC-chip has been used to identify cancer cells in the blood stream of lung, prostate, pancreas, breast and colon cancers.

A report in the New England Journal of Medicine finds the technology most useful in migrating cancer cells in the lung where a standard biopsy can cause the collapse of the lung or infection.  

Often standard scans may take months to show whether a tumor is growing, time a patient frequently cannot afford.

The device is not yet ready for widespread use and will be tested by larger groups of patients before it is routinely used.

Nanotechnology is not entirely without controversy. 

The National Institute for Occupational Safety and Health, under the CDC, wants to determine if inhaling carbon nanoparticles has the same effect on humans as asbestos. It is concerned the technology may pose risks for employees working in the nanoparticle industry. #


1 Comment

Anonymous User
Posted by geo magn
Thursday, July 03, 2008 5:30 PM EST

Sounds like the beginning of the end for cancer.
Early detection seems to be the only way to win.

Comments for this article are closed.

About the National News Desk

Our mission is to seek the complete truth and provide a full and fair account of the events and issues that surround personal safety, accident prevention, and injury recovery.  We are committed to serving the public with honesty and integrity in these efforts.

Hurt in an accident? Contact an Injury Board member

Subscribe to Blog Updates

Enter your email address if you would like to receive email notifications when comments are made on this post.

Email address

Subscribe

RSS Feed

Add the National News Desk to your favorite RSS reader

Add to Google Reader Add to myYahoo Add to myMSN Add to Bloglines Add to Newsgator Add to Netvibes Add to Pageflakes